WJA
PFE icon

Williams Jones & Associates’s Pfizer PFE Stock Holding History

Williams Jones & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$4.85M Sell
117,911
-17,664
-13% -$701K 0.1% 112
2019
Q1 		$5.46M Buy
135,575
+10,941
+9% +$438K 0.12% 103
2018
Q4 		$5.16M Sell
124,634
-3,233
-3% -$134K 0.14% 100
2018
Q3 		$5.35M Buy
127,867
+1,238
+1% +$47.7K 0.11% 126
2018
Q2 		$4.36M Sell
126,629
-30,399
-19% -$1.04M 0.1% 133
2018
Q1 		$5.29M Sell
157,028
-57,272
-27% -$1.97M 0.12% 117
2017
Q4 		$7.36M Sell
214,300
-13,849
-6% -$472K 0.17% 105
2017
Q3 		$7.73M Buy
228,149
+13,570
+6% +$436K 0.19% 98
2017
Q2 		$6.84M Sell
214,579
-66,602
-24% -$2.1M 0.17% 104
2017
Q1 		$9.13M Sell
281,181
-194,763
-41% -$6.14M 0.24% 91
2016
Q4 		$14.7M Sell
475,944
-213,914
-31% -$6.53M 0.42% 61
2016
Q3 		$22.2M Sell
689,858
-22,059
-3% -$738K 0.65% 51
2016
Q2 		$23.8M Buy
711,917
+173,370
+32% +$5.53M 0.73% 46
2016
Q1 		$15.1M Buy
538,547
+68,279
+15% +$1.95M 0.71% 45
2015
Q4 		$14.4M Buy
470,268
+4,181
+0.9% +$132K 0.66% 46
2015
Q3 		$13.9M Buy
466,087
+12,828
+3% +$411K 0.63% 49
2015
Q2 		$14.4M Buy
453,259
+84,601
+23% +$2.76M 0.55% 52
2015
Q1 		$12.2M Buy
368,658
+34,964
+10% +$1.11M 0.49% 60
2014
Q4 		$9.86M Buy
333,694
+95,757
+40% +$2.75M 0.4% 67
2014
Q3 		$6.67M Buy
237,937
+3,197
+1% +$89.7K 0.3% 81
2014
Q2 		$6.61M Sell
234,740
-358,805
-60% -$10.2M 0.3% 82
2014
Q1 		$18.1M Buy
593,545
+367,127
+162% +$10.9M 0.36% 71
2013
Q4 		$6.58M Sell
226,418
-2,020
-0.9% -$58.8K 0.32% 77
2013
Q3 		$6.23M Sell
228,438
-66,355
-23% -$1.81M 0.32% 78
2013
Q2 		$7.83M Buy
+294,793
New +$8.15M 0.39% 66

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Williams Jones & Associates's PFE Position: Q2 2019 in Review

Williams Jones & Associates reduced its Pfizer (PFE) stake by 13% in Q2 2019, selling an estimated $701K and leaving 117,911 shares worth $4.85M. The position accounts for 0.1% of the portfolio, ranked #112.

Williams Jones & Associates first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $23.8M in Q2 2016. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Williams Jones & Associates held 117,911 shares of Pfizer worth $4.85M as of Q2 2019.
  • Williams Jones & Associates sold 17,664 Pfizer shares in Q2 2019, an estimated $701K.
  • Pfizer made up 0.1% of Williams Jones & Associates's portfolio in Q2 2019, its #112 holding.
  • Williams Jones & Associates first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's Pfizer position peaked at $23.8M in Q2 2016.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.